Moxifloxacin Injection Shortage
Last Updated: September 25, 2018
Status: Resolved
Products Affected - Description
-
- Avelox I.V. injection, Bayer, 400 mg/250 mL, premixed bag, 12 count, NDC 50419-0537-01
Reason for the Shortage
-
- Bayer discontinued Avelox IV in December 2017.
- Fresenius Kabi had moxifloxacin injection on shortage due to increased demand.
- Mylan Institutional did not provide a reason for the shortage.
Available Products
-
- Moxifloxacin injection, Fresenius Kabi, 400 mg/250 mL, premixed bag, 12 count, NDC 63323-0850-74
- Moxifloxacin injection, Mylan Institutional, 400 mg/250 mL, premixed bag, 12 count, NDC 67457-0323-25
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated September 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 30, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.